Old Web
English
Sign In
Acemap
>
authorDetail
>
Annelore Cortoos
Annelore Cortoos
Novartis
Medicine
Deferasirox
Tolerability
Renal function
Thalassemia
3
Papers
52
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study
2017
American Journal of Hematology
Ali Taher
Raffaella Origa
Silverio Perrotta
Alexandra Kourakli
Giovan Battista Ruffo
Antonis Kattamis
Ai Sim Goh
Annelore Cortoos
Vicky Huang
Marine Weill
Raquel Merino Herranz
John B. Porter
Show All
Source
Cite
Save
Citations (45)
Improved Patient-Reported Outcomes with a Film-Coated Versus Dispersible Tablet Formulation of Deferasirox: Results from the Randomized, Phase II E.C.L.I.P.S.E. Study
2016
Blood
Ali Taher
Raffaella Origa
Silverio Perrotta
Alexandra Kouraklis
Giovan Battista Ruffo
Antonis Kattamis
Ai Sim Goh
Annelore Cortoos
Vicky Huang
Marine Weill
Raquel Merino Herranz
John B. Porter
Show All
Source
Cite
Save
Citations (4)
New Film-Coated Tablet Formulation of Deferasirox Is Well Tolerated in Patients with Thalassemia or MDS: Results of the Randomized, Phase II E.C.L.I.P.S.E. Study
2016
Blood
Ali Taher
Raffaella Origa
Silverio Perrotta
Alexandra Kouraklis
Giovan Battista Ruffo
Antonis Kattamis
Ai Sim Goh
Annelore Cortoos
Vicky Huang
Marine Weill
Raquel Merino Herranz
John B. Porter
Show All
Source
Cite
Save
Citations (3)
1